treosulfan has been researched along with Adenocarcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bojko, P; Dirsch, O; Hilger, RA; Ruehm, SG; Scheulen, ME; Seeber, S | 1 |
| Cree, IA; Di Nicolantonio, F; Glaysher, S; Johnson, P; Knight, LA; Mercer, S; Sharma, S; Whitehouse, P | 1 |
| Bibby, MC; Double, JA | 1 |
| Cree, I; Duncan, I; Evans, A; Kurbacher, C; Petty, R | 1 |
| Breidenbach, M; Kurbacher, CM; Mallmann, P; Rein, DT | 1 |
| Behr, J; Jäger, W; Paterok, EM; Thyselius, D | 1 |
| Aabo, K; Dombernowsky, P; Hald, I; Hansen, HH; Hørbov, S; Lundvall, F; Nielsen, NC; Sørensen, BL; Sørensen, HM | 1 |
1 review(s) available for treosulfan and Adenocarcinoma
| Article | Year |
|---|---|
[Primary metastasizing fallopian tube carcinoma. Case report and overview of current therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Busulfan; Cisplatin; Combined Modality Therapy; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis | 1990 |
1 trial(s) available for treosulfan and Adenocarcinoma
| Article | Year |
|---|---|
A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Random Allocation | 1985 |
5 other study(ies) available for treosulfan and Adenocarcinoma
| Article | Year |
|---|---|
Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Alkylating; Busulfan; Combined Modality Therapy; Female; Femur Head Necrosis; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiography | 2003 |
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours.
Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Colorectal Neoplasms; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Gefitinib; Gemcitabine; Humans; Melanoma; Neoplasms; Neoplasms, Unknown Primary; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Quinazolines; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Uveal Neoplasms | 2004 |
Characterisation and chemosensitivity of a well-differentiated murine transplantable adenocarcinoma of the colon.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Busulfan; Colonic Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Semustine; Time Factors | 1983 |
Drug resistance in ovarian cancer - the role of p53.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Busulfan; Cisplatin; Disease-Free Survival; Drug Resistance, Multiple; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Survival Rate; Tumor Suppressor Protein p53 | 1998 |
Individualized long-term chemotherapy for recurrent ovarian cancer after failing high-dose treatment.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Treatment Failure | 2002 |